Mohammed Milhem
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Vascular Tumors and Angiosarcomas
- Cutaneous Melanoma Detection and Management
- Immunology top 1%
- Immunotherapy and Immune Responses
Papers in
- Oncology 141
- CAR-T cell therapy research 61
- Cancer Immunotherapy and Biomarkers 57
- Vascular Tumors and Angiosarcomas 21
- Cutaneous Melanoma Detection and Management 18
- Co-authors
- Igor PuzanovClaus GarbeHoward L. KaufmanBrian Andrew Van TineLisa ChenRobert H.I. AndtbackaOmid HamidYousef Zakharia
- Journals
- Journal of Clinical Oncology (76 papers)Annals of Oncology (13 papers)Cancers (9 papers)Cancer Research (9 papers)Journal for ImmunoTherapy of Cancer (5 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Mohammed Milhem
218 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 4.2k
- Immunology 1.5k
- Pulmonary and Respiratory Medicine 2.0k
- Molecular Biology 2.5k
- Genetics 969
Countries citing papers authored by Mohammed Milhem
This map shows the geographic impact of Mohammed Milhem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Milhem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Milhem more than expected).
Fields of papers citing papers by Mohammed Milhem
This network shows the impact of papers produced by Mohammed Milhem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Milhem. The network helps show where Mohammed Milhem may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammed Milhem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 18 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 17 | |
| 13 | 2018 | 12 | |
| 14 | 2018 | 0 | |
| 15 | 2017 | 7 | |
| 16 | Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma Hit paper breakdown → | 2016 | 435 |
| 17 | 2016 | 23 | |
| 18 | Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial Hit paper breakdown → | 2015 | 576 |
| 19 | 2015 | 59 | |
| 20 | 2014 | 34 |
About Mohammed Milhem
Mohammed Milhem is a scholar working on Oncology, Biological Psychiatry, Immunology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 225 papers that have together received 6.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (61 papers), Cancer Immunotherapy and Biomarkers (57 papers), Sarcoma Diagnosis and Treatment (50 papers), Immunotherapy and Immune Responses (38 papers), Melanoma and MAPK Pathways (26 papers), Virus-based gene therapy research (26 papers), Vascular Tumors and Angiosarcomas (21 papers) and Cutaneous Melanoma Detection and Management (18 papers). The work is most often cited by research in Oncology (4.2k citations), Immunology (1.5k citations), Pulmonary and Respiratory Medicine (2.0k citations), Molecular Biology (2.5k citations) and Genetics (969 citations). Mohammed Milhem has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Igor Puzanov, Claus Garbe, Howard L. Kaufman, Brian Andrew Van Tine, Lisa Chen, Robert H.I. Andtbacka, Omid Hamid, Yousef Zakharia, Varun Monga and Lev Demidov. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, Cancer Research and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.